Press

For press enquiries, please email press@sanogenetics.com

Press kit

Places we've been featured

Guardian logo
Genomeweb logo
New Scientist logo

From the press

Tags: news ulcerative colitis inflammatory bowel disease Benevolent AI C4X Discovery Patients Know Best

Sano Genetics partners with BenevolentAI & C4X Discovery to power precision medicine in Inflammatory Bowel Disease

A new collaboration between Sano Genetics and industry partners aims to accelerate drug and biomarker discovery in ulcerative colitis (UC), a form of Inflammatory Bowel Disease (IBD).

Read more

03 Feb 2021

Tags: DNA science news

Sano Genetics accelerates research into Long Covid after raising £2.5M ($3.2M) in seed funding

The new funding is led by Episode1 Ventures, alongside Seedcamp, Cambridge Enterprise, January Ventures, and several UK, Europe, and US-based angel investors.

Read more

25 Jan 2021

About Sano Genetics

At Sano, we believe in a future where medicine is personalised to you, and we need your help to build it.

Data privacy and transparency are at the heart of everything we do, so users own and control all of their data. No information is ever shared without asking for consent first.

More